84.65

0.10% 0.14

Astrazeneca PLC (AZN)

Überblick Nachrichten Preisverlauf Optionskette Warum fällt AZN? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$84.51

Offen:

$84.58

24-Stunden-Volumen:

2.61M

Relative Volume:

0.53

Marktkapitalisierung:

$262.41B

Einnahmen:

$56.53B

Nettoeinkommen (Verlust:

$8.32B

KGV:

31.80

EPS:

2.6622

Netto-Cashflow:

$8.49B

1W Leistung:

-1.48%

1M Leistung:

+6.33%

6M Leistung:

+24.39%

1J Leistung:

+8.32%

1-Tages-Spanne:

$84.30

$84.84

1-Wochen-Bereich:

$83.84

$86.48

52-Wochen-Spanne:

$61.24

$86.57

Astrazeneca PLC Stock (AZN) Company Profile

Firmenname

Astrazeneca PLC

Sektor

Healthcare (1146)

Branche

Drug Manufacturers - Major (1)

Telefon

44 20 3749 5000

Adresse

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge

Mitarbeiter

61,100

Twitter

@AstraZeneca

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

AZN's Discussions on Twitter

Vergleichen Sie AZN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AZN Astrazeneca PLC	84.61	262.02B	56.53B	8.32B	8.49B	2.6622

Astrazeneca PLC Stock (AZN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-15	Eingeleitet	Exane BNP Paribas	Outperform
2025-02-13	Hochstufung	UBS	Neutral → Buy
2025-02-12	Eingeleitet	Morgan Stanley	Overweight
2024-11-20	Hochstufung	UBS	Sell → Neutral
2024-11-06	Hochstufung	Deutsche Bank	Sell → Hold
2024-09-13	Herabstufung	Deutsche Bank	Hold → Sell
2024-05-30	Eingeleitet	Goldman	Buy
2024-04-16	Hochstufung	Deutsche Bank	Sell → Hold
2024-02-08	Herabstufung	Deutsche Bank	Hold → Sell
2024-01-23	Eingeleitet	Morgan Stanley	Overweight
2024-01-16	Fortgesetzt	UBS	Sell
2024-01-03	Herabstufung	Jefferies	Buy → Hold
2023-12-18	Eingeleitet	HSBC Securities	Buy
2023-09-25	Hochstufung	Jefferies	Hold → Buy
2023-07-14	Eingeleitet	HSBC Securities	Buy
2023-07-12	Hochstufung	UBS	Neutral → Buy
2023-07-05	Herabstufung	Deutsche Bank	Buy → Hold
2023-04-11	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-01-05	Eingeleitet	BMO Capital Markets	Outperform
2022-09-15	Herabstufung	Credit Suisse	Outperform → Neutral
2022-09-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-08-29	Hochstufung	Argus	Hold → Buy
2022-06-14	Herabstufung	UBS	Buy → Neutral
2022-02-11	Hochstufung	DZ Bank	Sell → Hold
2021-12-07	Herabstufung	Jefferies	Buy → Hold
2021-08-12	Fortgesetzt	JP Morgan	Overweight
2021-04-12	Herabstufung	Argus	Buy → Hold
2021-03-16	Hochstufung	Jefferies	Hold → Buy
2021-02-25	Hochstufung	UBS	Neutral → Buy
2021-01-15	Eingeleitet	Deutsche Bank	Buy
2020-12-07	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-11-30	Hochstufung	UBS	Sell → Neutral
2020-11-11	Hochstufung	HSBC Securities	Reduce → Hold
2020-09-29	Eingeleitet	Berenberg	Buy
2019-11-22	Eingeleitet	SVB Leerink	Outperform
2019-10-25	Hochstufung	Liberum	Hold → Buy
2019-04-02	Herabstufung	UBS	Neutral → Sell
2019-02-05	Eingeleitet	Exane BNP Paribas	Outperform
2019-01-25	Hochstufung	Shore Capital	Hold → Buy
2018-12-11	Fortgesetzt	Jefferies	Hold
2018-10-09	Eingeleitet	Guggenheim	Buy
2018-08-16	Herabstufung	Jefferies	Buy → Hold
2018-03-19	Hochstufung	Jefferies	Hold → Buy
2018-02-06	Bestätigt	Leerink Partners	Mkt Perform
2018-02-05	Bestätigt	Bernstein	Outperform
2018-01-18	Bestätigt	Leerink Partners	Mkt Perform
2017-12-29	Hochstufung	JP Morgan	Neutral → Overweight
2017-10-16	Hochstufung	Credit Suisse	Neutral → Outperform
2017-09-25	Hochstufung	Exane BNP Paribas	Neutral → Outperform
2017-09-22	Hochstufung	Bernstein	Mkt Perform → Outperform

Alle ansehen

Astrazeneca PLC Aktie (AZN) Neueste Nachrichten

11:00 AM

AstraZeneca opens expanded facility in Texas - breakingthenews.net

11:00 AM

10:10 AM

AstraZeneca’s US listing plan backed by key shareholder advisers - The Times

10:10 AM

07:25 AM

Is AstraZeneca PLC Depositary Receipt stock ready for a breakoutMarket Sentiment Report & Daily Stock Trend Reports - newser.com

07:25 AM

06:46 AM

AstraZeneca reaches agreement with US government to reduce drug prices - Investing.com

06:46 AM

06:37 AM

Will breakout in AstraZeneca PLC Depositary Receipt lead to full recovery2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com

06:37 AM

06:22 AM

Goldman Sachs Sticks to Their Buy Rating for AstraZeneca (AZN) - The Globe and Mail

06:22 AM

06:20 AM

AstraZeneca reaches agreement with US government to reduce drug prices By Investing.com - Investing.com UK

06:20 AM

05:25 AM

UBS Keeps Their Buy Rating on AstraZeneca (AZN) - The Globe and Mail

05:25 AM

05:24 AM

Advanced analytics toolkit walkthrough for AstraZeneca PLC Depositary ReceiptJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com

05:24 AM

02:57 AM

Barclays Says AstraZeneca's US Drug Pricing Deal 'Strategically Constructive' - 富途牛牛

02:57 AM

01:21 AM

Astrazeneca to lower US prices amid Trump squeeze - MarketScreener

01:21 AM

Oct 13, 2025

Trump Strikes Again: AstraZeneca's Surprise Drug Deal Could Shake Big Pharma's Global Pricing Power - Yahoo

Oct 13, 2025

AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff Reprieve - The Globe and Mail

Oct 13, 2025

Why AstraZeneca PLC Depositary Receipt stock remains undervaluedWeekly Stock Recap & Target Return Focused Picks - newser.com

Oct 13, 2025

How to monitor AstraZeneca PLC Depositary Receipt with trend dashboardsMarket Growth Summary & Real-Time Chart Breakout Alerts - newser.com

Oct 13, 2025

Global markets live: Blackstone, Pfizer, Tesla, Stellantis, AstraZeneca… - MarketScreener

Oct 13, 2025

Will AstraZeneca PLC Depositary Receipt bounce back from current supportJuly 2025 Earnings & Real-Time Sentiment Analysis - newser.com

Oct 13, 2025

AstraZeneca (AZN) Agrees to Lower Drug Prices in the U.S. with S - GuruFocus

Oct 13, 2025

AstraZeneca's drug pricing deal with Trump far from clear result, say analysts - Proactive financial news

Oct 13, 2025

AstraZeneca inks Trump drug pricing deal amid tariff threats - Pharmaceutical Technology

Oct 13, 2025